Health & Life Sciences

Overview

“McDermott Will & Emery has a deep bench of healthcare attorneys and the firm is able to seamlessly leverage these internal resources to address any and all issues that arise.”

– Chambers USA

Today’s global healthcare marketplace is marked by unprecedented transformation and opportunity. Healthcare delivery and reimbursement is shifting toward value-based care and vertical consolidation at a rapid pace, as systems, health plans, and other forward-thinking leaders join forces to tackle some of the industry’s biggest challenges. Digital health solutions are evolving the doctor-patient relationship beyond the in-person encounter – fundamentally transforming the quality and delivery of healthcare. And investors are taking notice.

If you’re doing something that’s never been done before, or looking to do something better than it’s ever been done before, we’re here to help.

We collaborate with those at the forefront of health industry innovation to foster the unique partnerships and business ventures that are transforming healthcare.

Exclusively serving the health industry, our policy and lobbying team, McDermott+, uses data-driven insights, experience, and analytics to tackle challenges, identify alternatives, and implement strategies when clients are faced with legislative and regulatory obstacles that challenge their market objectives, business operations, and opportunities.

Upcoming Events

McDermott events provide exciting networking opportunities and unique programming that offer insight into the healthcare and life sciences industries. These events are attended by leading providers, investors, founders, and other senior leaders.

View Upcoming Events

2025 JD Supra Readers Choice Awards Recognize McDermott as the Top Firm for Healthcare

Providing leading insights to keep you ahead of the curve

Learn More

AI in Healthcare Law Center

We continue to closely monitor the state of AI in healthcare to help you maximize the value of data and AI with an eye toward compliance in this rapidly evolving regulatory landscape.

Learn More

Health Transactions Resource Center

Visit this legal resource center to cut the complexity and learn about the latest regulatory developments impacting healthcare transactions.

Learn More

Results

Geisinger Health, a $10 billion health provider, health insurer, and medical school, in its acquisition by Kaiser. The transaction is the first major acquisition of a new affiliate of Kaiser known as Risant Health, a nonprofit landmark initiative to promote better health outcomes and increase access to affordable care.
Northwell Health in its proposed affiliation with Nuvance Health, a nonprofit diversified healthcare system comprised of six hospitals across seven campuses and two states, more than 110 ambulatory locations, 1,300 employed doctors and providers, and approximately 14,000 staff. The proposed affiliation is the largest and most complicated hospital system transaction in New York and Connecticut history.
CVS Health as health regulatory counsel in two strategic acquisitions of leading companies in the healthcare sector: (a) the closing of its $10.6 billion acquisition of Oak Street Health, a leading multi-payor, value-based primary care company, and (b) its $8 billion definitive agreement to acquire Signify Health, Inc., a leader in health risk assessments, value-based care, and provider enablement.

Prime Therapeutics, a pharmacy benefits manager, in its strategic expansion and first ever M&A deal through a $1.35 billion carve-out acquisition of Magellan RX Management, a leading pharmacy benefit management company, from Centene Corp., a diversified healthcare enterprise. We also represented Prime Therapeutics in its software licensing and equity investment in Capital Rx, a pharmacy benefits administration platform that provides innovative solutions for drug pricing and benefits design.
Amulet Capital Partners and its platform company, US Fertility, a nationwide fertility focused physician practice management platform providing non-clinical and administrative services to physician-owned fertility practices, in its acquisition of Ovation Fertility, a leading national network of reproductive endocrinologists and scientific thought leaders. McDermott previously advised Amulet Capital Partners in its partnership with Shady Grove Fertility, the largest independent fertility practice in the US, to form US Fertility.
Lee Equity Partners in its partnership with Cardiovascular Institute of the South, one of the largest independent cardiovascular practices in the country, to launch a national cardiovascular platform: Cardiovascular Logistics. The launch of Cardiovascular Logistics will build a network of cardiovascular practices across the nation. McDermott subsequently guided Cardiovascular Logistics in its collaboration with First Coast Cardiovascular Institute.
Compass Surgical Partners, LLC, an independent, full-service ambulatory surgery center development and management partner, in its partnership and significant strategic investment by TPG Growth, middle-market and growth equity platform of TPG Inc., a global alternative asset management firm.
Numerous clients with platforms related to weight loss, food intake, and exercise in the development of national weight-loss programs that leverage Glucagon-like peptide-1 (GLP-1) and other innovative medication treatment plans, such as personal coaching and compounded medications.